Tectonic Therapeutic Q3 2026 Results: Net Loss of $21.3M, Loss Widens
Tectonic Therapeutic reported a net loss of $68.9 million for the nine months ended September 30, 2026, compared to $54.9 million in the prior year period, driven primarily by increased research and development expenses. The company maintained a strong cash position with $234.7 million in cash and cash equivalents as of the end of the third quarter.
- Key figure
- Net loss $21.3M